#Coronavirus Disease Research #References (AMEDEO, May 30 '26)

 

Antiviral Res

1. MALOCCU S, Otsuka Y, Molchan E, Foti M, et al
   Identification of Nsp15 inhibitors restoring interferon-dependent antiviral activity against SARS-CoV-2.
   Antiviral Res. 2026;251:106443.
   PubMed         Abstract available
   
   

   
   BMJ

2. YAMEY G
   Trump and RFK Jr have a new approach to global health: holding vulnerable people to ransom.
   BMJ. 2026;393:e387444.
   PubMed        
   
   

   
   Graefes Arch Clin Exp Ophthalmol

3. XU X, Yu P, Wu S, Wang L, et al
   Repeatability of corneal diameter measured by Sirius versus IOLMaster 700 in myopic eyes: combined with consistency and relationship of sulcus-to-sulcus.
   Graefes Arch Clin Exp Ophthalmol. 2026 May 23. doi: 10.1007/s00417-026-07281.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

4. GIBAS KM, Head T, Broadley M, Mermel LA, et al
   Healthcare personnel masking: current practices and gaps in standardized thresholds.
   Infect Control Hosp Epidemiol. 2026 May 26:1-8. doi: 10.1017/ice.2026.10469.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

5. BRUNVOLL SH, Fagerland MW, Nygaard AB, Ellingjord-Dale M, et al
   Long COVID symptoms before and 3-35 Months after SARS-CoV-2 infection in a Norwegian prospective cohort study, symptoms over the pandemic and different virus variants.
   Int J Infect Dis. 2026 May 27:108822. doi: 10.1016/j.ijid.2026.108822.
   PubMed         Abstract available
   
   

   
   J Infect

6. LU L, Long Z, Chen F, Li Z, et al
   Global Disability-Adjusted Life Years Burden of Lower Respiratory Infections Caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990-2021: A Systematic Analysis of the Global Burden of Disease Study 2021.
   J Infect. 2026 May 25:106768. doi: 10.1016/j.jinf.2026.106768.
   PubMed         Abstract available
   
   
7. CORRAO G, Sguazzini E, Gori A, Monti E, et al
   All-cause mortality within seven days of COVID-19 vaccination: A matched cohort and self-controlled case series study in Lombardy, Italy.
   J Infect. 2026;93:106769.
   PubMed         Abstract available
   
   

   
   J Med Virol

8. 
   Correction to "Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants".
   J Med Virol. 2026;98:e70987.
   PubMed        
   
   
9. REPUSIC D, Korolija M, Livun A, Svagusa T, et al
   Multi-Layered Genomic and Clinical Analysis Identifies Novel Variants, Co-Occurring Single Nucleotide Polymorphism Pairs, and Clinical Determinants of Host-Pathogen Interaction in COVID-19 Severity.
   J Med Virol. 2026;98:e70984.
   PubMed         Abstract available
   
   

   
   Lancet

10. GIOVANNONI G, Airas L, Bove R, Cutter GR, et al
    Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
    Lancet. 2026;407:2195-2207.
    PubMed         Abstract available
    
    

    
    N Engl J Med

11. ZIMMERMANN WH, Ensminger S, Kutschka I, Paitazoglou C, et al
    Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.
    N Engl J Med. 2026;394:1991-2001.
    PubMed         Abstract available
    
    

    
    Nature

12. SUZUKI R, Yamasoba D, Kimura I, Wang L, et al
    Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
    Nature. 2026 May 29. doi: 10.1038/s41586-026-10665.
    PubMed        
    
    
13. ZENG AGX, Nagree MS, Jakobsen NA, Shah S, et al
    Human haematopoietic stem cells remember inflammatory stress.
    Nature. 2026 May 27. doi: 10.1038/s41586-026-10522.
    PubMed         Abstract available
    
    

    
    Radiology

14. SPOSATO A, Mazzola MA, Kunst MM
    Case 346: gamma-Aminobutyric Acid A Receptor Encephalitis.
    Radiology. 2026;319:e251976.
    PubMed         Abstract available